Alzheimer Mechanisms and Therapeutic Strategies

Huang, Yadong, Mucke, Lennart·2012·Cell

Cited by (1,005)

Items 701–800 of 1,005

  1. Amyloid β induces interneuron-specific changes in the hippocampus of APPNL-F mice
    Sos, Katalin E., Mayer, Márton I., Takács, Virág T., Major, Abel, Bardóczi, Zsuzsanna, Beres, Barnabas M., Szeles, Tamás, Saito, Takashi, Saido, Takaomi C., Mody, István et al. · 2020 · PLOS ONE
  2. Synthesis and in silico studies of triazene‐substituted sulfamerazine derivatives as acetylcholinesterase and carbonic anhydrases inhibitors
    Sinan Bilginer, Halise Inci Gul, Barış Anıl, Yeliz Demir, İlhami Gülçın · 2020 · Archiv der Pharmazie
  3. Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies
    Tao Yang, Kevin C Tran, Anne Y. Zeng, Stephen M. Massa, Frank M. Longo · 2020 · Scientific Reports
  4. ATP-sensitive Potassium Channel Subunits in Neuroinflammation: Novel Drug Targets in Neurodegenerative Disorders
    Fatima Maqoud, Rosa Scala, Malvina Hoxha, Bruno Zappacosta, Domenico Tricarico · 2021 · CNS & Neurological Disorders - Drug Targets
  5. Current druggable targets for therapeutic control of Alzheimer's disease
    Girdhari Lal Gupta, Nikita Patil Samant · 2021 · Contemporary Clinical Trials
  6. Development and in vivo Evaluation of Hydroxy-α-Sanshool Intranasal Liposomes as a Potential Remedial Treatment for Alzheimer’s Disease
    Ruolan Li, Feng Lu, Xue Sun, Li-Ying He, Huxinyue Duan, W. Peng, Chunjie Wu · 2022 · International Journal of Nanomedicine
  7. Levetiracetam alleviates cognitive decline in Alzheimer’s disease animal model by ameliorating the dysfunction of the neuronal network
    Xiangyu Zheng, Yu-Dan Lv, Fengyan Jin, Haichen Zhang, Xiujuan Wu, Jie Zhu, Yang Ruan · 2022 · Frontiers in Aging Neuroscience
  8. Selenomethionine reduces the deposition of beta-amyloid plaques by modulating β-secretase and enhancing selenoenzymatic activity in a mouse model of Alzheimer's disease
    Zhong-Hao Zhang, Chen Chen, Qiuyan Wu, Rui Zheng, Qiong Liu, Jiazuan Ni, Peter R. Hoffmann, Guo-Li Song · 2016 · Metallomics
  9. Association of periodontitis with cognitive decline and its progression: Contribution of blood‐based biomarkers of Alzheimer's disease to this relationship
    Álvaro Carballo, Iria López‐Dequidt, Antía Custodia, João Botelho, Marta Aramburu-Núñez, Vanessa Machado, Juan Manuel Pías Peleteiro, Alberto Ouro, Daniel Romaus‐Sanjurjo, Laura Vázquez‐Vázquez et al. · 2023 · Journal Of Clinical Periodontology
  10. Methyllycaconitine Alleviates Amyloid-β Peptides-Induced Cytotoxicity in SH-SY5Y Cells
    Xiaolei Zheng, Zhaohong Xie, Zhengyu Zhu, Zhen Liu, Yun Wang, LiFei Wei, Hui Yang, Hongna Yang, Yiqing Liu, Jianzhong Bi · 2014 · PLoS ONE
  11. Beta-amyloid peptides undergo regulated co-secretion with neuropeptide and catecholamine neurotransmitters
    T. Toneff, Lydiane Funkelstein, Charles Mosier, Armen Abagyan, Michael Ziegler, V. Hook · 2013 · Peptides
  12. TAR DNA-Binding Protein 43 and Disrupted in Schizophrenia 1 Coaggregation Disrupts Dendritic Local Translation and Mental Function in Frontotemporal Lobar Degeneration
    Ryo Endo, Noriko Takashima, Yoko Nekooki-Machida, Yusuke Komi, Kelvin K. Hui, Masaki Takao, Hiroyasu Akatsu, Shigeo Murayama, Akira Sawa, Motomasa Tanaka · 2018 · Biological Psychiatry
  13. BACE1 Inhibitory Meroterpenoids from Aspergillus terreus
    Changxing Qi, Mengting Liu, Qun Y. Zhou, Weixi Gao, Chunmei Chen, Yongji Lai, Zhengxi Hu, Yongbo Xue, Jinwen Zhang, Dongyan Li et al. · 2018 · Journal of Natural Products
  14. New 3,5-dimethylorsellinic acid-based meroterpenoids with BACE1 and AchE inhibitory activities from Aspergillus terreus
    Changxing Qi, Yuben Qiao, Weixi Gao, Mengting Liu, Qun Y. Zhou, Chunmei Chen, Yongji Lai, Yongbo Xue, Jinwen Zhang, Dongyan Li et al. · 2018 · Organic & Biomolecular Chemistry
  15. Early Stage Glycosylation Biomarkers in Alzheimer’s Disease
    Patricia Regan, Paula L. McClean, Thomas J. Smyth, Margaret Doherty · 2019 · Medicines
  16. Profiling of differentially expressed circular RNAs in peripheral blood mononuclear cells from Alzheimer’s disease patients
    Yanxin Li, Zhanyun Lv, Jing Zhang, Qianqian Ma, Qiuhua Li, Li Song, Li Gong, Yunliang Zhu, Xiangyuan Li, Yanlei Hao et al. · 2019 · Metabolic Brain Disease
  17. Naphthalene Monoimide Derivative Ameliorates Amyloid Burden and Cognitive Decline in a Transgenic Mouse Model of Alzheimer's Disease
    Sourav Samanta, Kolla Rajasekhar, Madhu Ramesh, N. Arul Murugan, Shadab Alam, Devanshi Shah, James Premdoss Clement, Thimmaiah Govindaraju · 2021 · Advanced Therapeutics
  18. Andrographolide ameliorates neuroinflammation in APP/PS1 transgenic mice
    Jiawei Zhang, Yaling Zheng, Yao Zhao, Yaxuan Zhang, Yu Liu, Fang Ma, Xiuzhe Wang, Jianliang Fu · 2021 · International Immunopharmacology
  19. ErbB4 mediates amyloid β‐induced neurotoxicity through JNK /tau pathway activation: Implications for Alzheimer's disease
    Heng Zhang, Ling Zhang, Dongming Zhou, Hongfei Li, Yang Y. Xu · 2021 · The Journal of Comparative Neurology
  20. Beta-Amyloid Oligomers Activate Apoptotic BAK Pore for Cytochrome c Release
    Jaewook Kim, Yoosoo Yang, Seung Soo Song, Jung‐Hyun Na, Kyoung Joon Oh, Cherlhyun Jeong, Yeon Gyu Yu, Yeon‐Kyun Shin · 2014 · Biophysical Journal
  21. TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer’s Disease Subjects
    Ayano Mise, Yuta Yoshino, Kiyohiro Yamazaki, Yuki Ozaki, Tomoko Sao, Taku Yoshida, Takaaki Mori, Yoko Mori, Shinichiro Ochi, Jun‐ichi Iga et al. · 2017 · Journal of Alzheimer s Disease
  22. Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery
    Shibing Tang, Min Xie, Nan Cao, Sheng Ding · 2015 · Journal of Medicinal Chemistry
  23. Molecular regulation of synaptogenesis during associative learning and memory
    Thomas J. Nelson, Daniel L. Alkon · 2014 · Brain Research
  24. Chaperone Nanobodies Protect Gelsolin Against MT1-MMP Degradation and Alleviate Amyloid Burden in the Gelsolin Amyloidosis Mouse Model
    Wouter Van Overbeke, Adriaan Verhelle, Inge Everaert, Olivier Zwaenepoel, Joel S. Vandekerckhove, Claude A Cuvelier, Wim Derave, Jan Gettemans · 2014 · Molecular Therapy
  25. Lipids under stress – a lipidomic approach for the study of mood disorders
    André Miguel Miranda, Tiago Gil Oliveira · 2015 · BioEssays
  26. Yeast buddies helping to unravel the complexity of neurodegenerative disorders
    Gernot Fruhmann, David Seynnaeve, Ju Zheng, Karen Ven, Sofie Molenberghs, Tobias Wilms, Beidong Liu, Joris Winderickx, Vanessa Franssens · 2016 · Mechanisms of Ageing and Development
  27. Coriandrum sativumSuppresses Aβ42-Induced ROS Increases, Glial Cell Proliferation, and ERK Activation
    Quan Feng Liu, Haemin Jeong, Jang Ho Lee, Yoon Ki Hong, Youngje Oh, Young‐Mi Kim, Yoon Seok Suh, Se Min Bang, Hye Sup Yun, Kyung‐Ho Lee et al. · 2016 · The American Journal of Chinese Medicine
  28. Rate of β‐amyloid accumulation varies with baseline amyloid burden: Implications for anti‐amyloid drug trials
    Tengfei Guo, Juergen Dukart, Matthias Brendel, Axel Rominger, Timo Grimmer, Igor Y. Yakushev, Alzheimer’s Disease Neuroimaging Initiative · 2018 · Alzheimer s & Dementia
  29. Incidence of dementia in patients with adult-onset epilepsy of unknown causes
    Osamu Kawakami, Yasuo Koike, Tetsuo Ando, Makoto Sugiura, Hiroko Kato, Keita Hiraga, Hiroshi Kito, Hajime KONDO · 2018 · Journal of the Neurological Sciences
  30. Involvement of GAT2/BGT-1 in the preventive effects of betaine on cognitive impairment and brain oxidative stress in amyloid β peptide-injected mice
    Daisuke Ibi, Azumi Tsuchihashi, Tomohiro Nomura, Masayuki Hiramatsu · 2018 · European Journal of Pharmacology
  31. Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases
    Сергей Олегович Бачурин, Галина Ф. Махаева, E. F. Shevtsova, Natalia P. Boltneva, Надежда Владимировна Ковалева, Sofya V. Lushchekina, Елена Владимировна Рудакова, L. G. Dubova, Daria V. Vinogradova, Vladimir B. Sokolov et al. · 2019 · Scientific Reports
  32. Histological characterization of interneurons in Alzheimer's disease reveals a loss of somatostatin interneurons in the temporal cortex
    Rachel Waller, Memory Mandeya, Edward Viney, Julie E. Simpson, Stephen B. Wharton · 2020 · Neuropathology
  33. Anti-autophagic and anti-apoptotic effects of memantine in a SH-SY5Y cell model of Alzheimer's disease via mammalian target of rapamycin-dependent and -independent pathways
    Guijun Song, YU LI, Lu‐Lu Lin, Yunpeng Cao · 2015 · Molecular Medicine Reports
  34. Bathing the brain
    Warren J. Strittmatter · 2013 · Journal of Clinical Investigation
  35. Chronic Cerebral Hypoperfusion Induced Synaptic Proteome Changes in the rat Cerebral Cortex
    Katalin Völgyi, Péter Gulyássy, Mihail Ivilinov Todorov, Gina Puska, Kata Badics, Dávid Hlatky, Katalin Adrienna Kékesi, Gabriella Nyitrai, András Czurkó, László Drahos et al. · 2017 · Molecular Neurobiology
  36. Spatial memory deficits in a mouse model of late-onset Alzheimer’s disease are caused by zinc supplementation and correlate with amyloid-beta levels
    Jane M. Flinn, P. Lorenzo Bozzelli, Paul Anthony Adlard, Angela M. Railey · 2014 · Frontiers in Aging Neuroscience
  37. Production of Glycosylated Soluble Amyloid Precursor Protein Alpha (sAPPalpha) in Leishmania tarentolae
    Stephan Klatt, Michael Rohe, Kathirvel Alagesan, Daniel Kolarich, Zoltán Konthur, Daniela Hartl · 2012 · Journal of Proteome Research
  38. Influence of four polymorphisms in ABCA1 and PTGS2 genes on risk of Alzheimer’s disease: a meta-analysis
    Qicong Chen, Biyu Liang, Ziyou Wang, Xiaoguang Cheng, Yifeng Huang, Yong Liu, Zunnan Huang · 2016 · Neurological Sciences
  39. Stem cells as a promising therapeutic approach for Alzheimer’s disease: a review
    Ghadha Ibrahim Fouad · 2019 · Bulletin of the National Research Centre/Bulletin of the National Research Center
  40. Rationale for the development of an Alzheimer’s disease vaccine
    Ping Kwan, Haruki Konno, Ka Yan Chan, Larry Baum · 2019 · Human Vaccines & Immunotherapeutics
  41. Increasing the Receptor Tyrosine Kinase EphB2 Prevents Amyloid-β-induced Depletion of Cell Surface Glutamate Receptors by a Mechanism That Requires the PDZ-binding Motif of EphB2 and Neuronal Activity
    Miyamoto, Takashi, Kim, Daniel, Knox, Joseph A., Johnson, Erik, Mucke, Lennart · 2016 · Journal of Biological Chemistry
  42. Lantana camara leaf extract ameliorates memory deficit and the neuroinflammation associated with scopolamine-induced Alzheimer’s-like cognitive impairment in zebrafish and mice
    Veronica Amoah, Paul Atawuchugi, Jibira Yakubu, Augustine Tandoh, Paul Poku Sampene Ossei, George Henry Sam ., George K. Ainooson · 2023 · Pharmaceutical Biology
  43. Anti-inflammatory effect of dental pulp stem cells
    FenYao Li, Xinxin Wang, Jin Shi, ShuTing Wu, WenBo Xing, Yan He · 2023 · Frontiers in Immunology
  44. Disease- and stage-specific alterations of the oral and fecal microbiota in Alzheimer's disease
    Alba Troci, Sarah Philippen, Philipp Rausch, Julius Rave, Gina Weyland, Katharina Niemann, Katharina Jessen, Lars-Patrick Andreas Schmill, Schekeb Aludin, André Franke et al. · 2023 · PNAS Nexus
  45. Revolutionizing Alzheimer's treatment: Harnessing human serum albumin for targeted drug delivery and therapy advancements
    Divya Shastri, Vinit Raj, Sang-Kil Lee · 2024 · Ageing Research Reviews
  46. Long non-coding RNAs in Alzheimer's disease
    Zijian Zhang · 2015 · Current Topics in Medicinal Chemistry
  47. Effects of structural modifications on the metal binding, anti-amyloid activity, and cholinesterase inhibitory activity of chalcones
    Marina Y. Fosso, Harry LeVine, Keith D. Green, Oleg V. Tsodikov, Sylvie Garneau‐Tsodikova · 2015 · Organic & Biomolecular Chemistry
  48. 9H‐Carbazole Derivatives Containing the N‐Benzyl‐1,2,3‐triazole Moiety as New Acetylcholinesterase Inhibitors
    Hamidreza Akrami, B. F. Mirjalili, Mehdi Khoobi, Alireza Moradi, Hamid Nadri, Saeed Emami, Alireza Foroumadi, Mohsen Vosooghi, Abbas Shafiee · 2015 · Archiv der Pharmazie
  49. From Traditional European Medicine to Discovery of New Drug Candidates for the Treatment of Dementia and Alzheimer's Disease: Acetylcholinesterase Inhibitors
    Patrizia Russo, Alessandra Frustaci, A. Del Bufalo, Milena Fini, Alfredo Cesario · 2013 · Current Medicinal Chemistry
  50. Ion channel regulation by β-secretase BACE1 – enzymatic and non-enzymatic effects beyond Alzheimer's disease
    Sandra Lehnert, Stephanie Hartmann, Sabine Hessler, Helmuth Adelsberger, Tobias Huth, Christian Alzheimer · 2016 · Channels
  51. Multifunctional Mono-Triazole Derivatives Inhibit Aβ42 Aggregation and Cu2+-Mediated Aβ42 Aggregation and Protect Against Aβ42-Induced Cytotoxicity
    Amandeep Kaur, Simranjeet Singh Narang, Anupamjeet Kaur, Sukhmani Mann, Nitesh Priyadarshi, Bhupesh Goyal, Nitin Kumar Singhal, Deepti Goyal · 2019 · Chemical Research in Toxicology
  52. SCM-198 Ameliorates Cognitive Deficits, Promotes Neuronal Survival and Enhances CREB/BDNF/TrkB Signaling without Affecting Aβ Burden in AβPP/PS1 Mice
    Zhenyi Hong, Shuang‐Shuang Yu, Zhijun Wang, Yi Zhun Zhu · 2015 · International Journal of Molecular Sciences
  53. Functional MRI and neural responses in a rat model of Alzheimer's disease
    Basavaraju G. Sanganahalli, Péter Hermán, Kevin L. Behar, Hal Blumenfeld, Douglas L. Rothman, Fahmeed Hyder · 2013 · NeuroImage
  54. The structural biology of the amyloid precursor protein APP – a complex puzzle reveals its multi-domain architecture
    Ina Coburger, Sandra Hoefgen, Manuel E. Than · 2014 · Biological Chemistry
  55. Increased acetylation of microtubules rescues human tau-induced microtubule defects and neuromuscular junction abnormalities in Drosophila
    Chuan‐Xi Mao, Xue Wen, Shan Jin, Yongqing Zhang · 2017 · Disease Models & Mechanisms
  56. Sulfur Nanoparticles with Novel Morphologies Coupled with Brain-Targeting Peptides RVG as a New Type of Inhibitor Against Metal-Induced Aβ Aggregation
    Jing Sun, Wenjie Xie, Xufeng Zhu, Mengmeng Xu, Jie Liu · 2017 · ACS Chemical Neuroscience
  57. Apple Cider Vinegar (ACV) and Their Pharmacological Approach towards Alzheimer’s Disease (AD): A Review
    Tripathi, Smriti, Mazumder, Papiya Mitra · 2020 · Indian Journal of Pharmaceutical Education and Research
  58. Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer’s Disease: From In Silico to In Vivo
    Stern, Noa, Gacs, Alexandra, Tátrai, Enikő, Flachner, Beáta, Hajdú, István, Dobi, Krisztina, Bágyi, István, Dormán, György, Lőrincz, Zsolt, Cseh, Sándor et al. · 2022 · International Journal of Molecular Sciences
  59. Chemical Synthesis Reveals Pathogenic Role of N-Glycosylation in Microtubule-Associated Protein Tau
    Wyatt C. Powell, Ruiheng Jing, Morgane Herlory, Patrick Holland, Darya Poliyenko, Christopher C. Ebmeier, Michael H. B. Stowell, Maciej A. A. Walczak · 2025 · Journal of the American Chemical Society
  60. The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders
    Derek K. Smith, Miao He, Chun-Li Zhang, Jia-Lin C. Zheng · 2016 · Progress in neurobiology
  61. Expression of B4GALNT1, an essential glycosyltransferase for the synthesis of complex gangliosides, suppresses BACE1 degradation and modulates APP processing
    T. Yamaguchi, Y. Yamauchi, K. Furukawa, Yuhsuke Ohmi, Yuki Ohkawa, Qing Zhang, T. Okajima, Kazuro Furukawa · 2016 · Scientific Reports
  62. Anti-BACE1 and anti-AchE activities of undescribed spiro-dioxolane-containing meroterpenoids from the endophytic fungus Aspergillus terreus Thom
    Changxing Qi, Qun Y. Zhou, Weixi Gao, Mengting Liu, Chunmei Chen, Xiao‐Nian Li, Yongji Lai, Yuan Zhou, Dongyan Li, Zhengxi Hu et al. · 2019 · Phytochemistry
  63. Synthesis and in vitro study of new coumarin derivatives linked to nicotinonitrile moieties as potential acetylcholinesterase inhibitors
    Ahmed E. M. Mekky, Sherif M. H. Sanad · 2020 · Journal of Heterocyclic Chemistry
  64. Review of Advanced Drug Trials Focusing on the Reduction of Brain Beta-Amyloid to Prevent and Treat Dementia
    Boris Decourt, Keith Noorda, Kevin J. Noorda, Jiong Shi, Marwan Noel Sabbagh · 2022 · Journal of Experimental Pharmacology
  65. GSTM1 Null Genotype and GSTP1 Ile105Val Polymorphism Are Associated with Alzheimer’s Disease: a Meta-Analysis
    Mo Wang, Li Yu, Lu‐Lu Lin, Guijun Song, Teng Deng · 2015 · Molecular Neurobiology
  66. Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers
    Gaël Chételat, Marine Fouquet · 2013 · Revue Neurologique
  67. Animal models of source memory
    Jonathon D. Crystal · 2015 · Journal of the Experimental Analysis of Behavior
  68. Disease implication of hyper-Hippo signalling
    Shu‐Ping Wang, Lan-Hsin Wang · 2016 · Open Biology
  69. Sortilin-Related Receptor Expression in Human Neural Stem Cells Derived from Alzheimer’s Disease Patients Carrying the APOE Epsilon 4 Allele
    Alen Zollo, Zoe Allen, Helle Foverskov Rasmussen, Filomena Iannuzzi, Yichen Shi, Agnete Larsen, Thorsten J. Maier, Carmela Matrone · 2017 · Neural Plasticity
  70. A novel molecular class that recruits HDAC/MECP2 complexes to PU.1 motifs reduces neuroinflammation
    Ralvenius, William T., Mungenast, Alison E., Woolf, Hannah, Huston, Margaret M., Gillingham, Tyler Z., Godin, Stephen K., Penney, Jay, Cam, Hugh P., Gao, Fan, Fernandez, Celia G. et al. · 2023 · Journal of Experimental Medicine
  71. New animal models of Alzheimer’s disease that display insulin desensitization in the brain
    Chong Gao, Yueze Liu, Lin Li, Christian Hölscher · 2013 · Reviews in the Neurosciences
  72. Anti-Neuroinflammatory Agents for the Treatment of Alzheimer’s Disease
    Wei Zhou, Wenhui Hu · 2013 · Future Medicinal Chemistry
  73. Screening strategies to identify HSP70 modulators to treat Alzheimer’s disease
    Jayanthi Repalli, Daniel Meruelo · 2015 · Drug Design Development and Therapy
  74. Induction of Amyloid-β 42 Production by Fipronil and Other Pyrazole Insecticides
    Morgane Cam, Émilie Durieu, Marion Bodin, Antigoni Manousopoulou, Svenja Koslowski, Natalia Vasylieva, Bogdan B. Barnych, Bruce D. Hammock, Bettina Bohl, Philipp Koch et al. · 2018 · Journal of Alzheimer s Disease
  75. Autophagy and lysosomal pathways in nervous system disorders
    Baris Bingol · 2018 · Molecular and Cellular Neuroscience
  76. Condition-specific gene co-expression network mining identifies key pathways and regulators in the brain tissue of Alzheimer’s disease patients
    Shunian Xiang, Zhi Huang, Tianfu Wang, Zhi Han, Christina Y. Yu, Dong Ni, Kun Huang, Jie Zhang · 2018 · BMC Medical Genomics
  77. The therapeutic potential of galectin-1 and galectin-3 in the treatment of neurodegenerative diseases
    Eleazar Ramírez Hernández, Claudia Sánchez-Maldonado, Miguel Ángel Mayoral Chávez, Luis Fernando Hernández-Zimbrón, Aleidy Patricio-Martínez, Edgar Zenteno, Ilhuicamina Daniel Limón · 2020 · Expert Review of Neurotherapeutics
  78. The Role and Mechanisms of Action of Catechins in Neurodegenerative Diseases
    Gülşen Özduran, Eda Becer, Hafize Seda Vatansever · 2021 · Journal of the American Nutrition Association
  79. A multifunctional anti-AD approach: Design, synthesis, X-ray crystal structure, biological evaluation and molecular docking of chrysin derivatives
    Ai‐Hong Yang, Chang Liu, Hongwei Zhang, Jianhua Wu, Rui Shen, Xiaodi Kou · 2022 · European Journal of Medicinal Chemistry
  80. Alzheimer’s Disease, Astrocytes and Kynurenines
    Lívia Dézsi, Bernadett Tuka, Diána Martos, László Vécsei · 2015 · Current Alzheimer Research
  81. Designing of dual inhibitors for GSK-3β and CDK5: Virtual screening andin vitrobiological activities study
    Hongbo Xie, Haixia Wen, Denan Zhang, Lei Liu, Bo Liu, Qiuqi Liu, Qing Jin, Kehui Ke, Ming Hu, Xiujie Chen · 2017 · Oncotarget
  82. Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer’s Disease drug candidate
    Nemergut, Michal, Marques, Sérgio M., Uhrik, Lukas, Vanova, Tereza, Nezvedova, Marketa, Gadara, Darshak Chandulal, Jha, Durga, Tulis, Jan, Novakova, Veronika, Planas-Iglesias, Joan et al. · 2023 · Molecular Neurodegeneration
  83. Somatostatin and the pathophysiology of Alzheimer’s disease
    Victor Nascimento Almeida · 2024 · Ageing Research Reviews
  84. Revealing excitation-inhibition imbalance in Alzheimer’s disease using multiscale neural model inversion of resting-state functional MRI
    Guoshi Li, Li‐Ming Hsu, Ye Wu, Andrea Bozoki, Yen‐Yu Ian Shih, Pew‐Thian Yap · 2025 · Communications Medicine
  85. Toxicity Inhibitors Protect Lipid Membranes from Disruption by Aβ42
    Ravit Malishev, Sukhendu Nandi, Sofiya Kolusheva, Yael Levi‐Kalisman, Frank‐Gerrit Klärner, Thomas H. Schrader, Gal Bitan, Raz Jelinek · 2015 · ACS Chemical Neuroscience
  86. Common variant in PTK2B is associated with late-onset Alzheimer’s disease: A replication study and meta-analyses
    Yaqing Li, Meng‐Shan Tan, Hui-Fu Wang, Chen‐Chen Tan, Wei Zhang, Zhan-Jie Zheng, Lingli Kong, Zi-Xuan Wang, Lin Tan, Teng Jiang et al. · 2016 · Neuroscience Letters
  87. Magnetic Resonance Imaging of Ferumoxytol-Labeled Human Mesenchymal Stem Cells in the Mouse Brain
    Na Kyung Lee, Hyeongseop Kim, Dongkyeom Yoo, Jung Won Hwang, Soo Jin Choi, Wonil Oh, Jong Wook Chang, Duk Lyul Na · 2016 · Stem Cell Reviews and Reports
  88. Multi-Target β-Protease Inhibitors from Andrographis paniculata: In Silico and In Vitro Studies
    Archana N. Panche, Sheela Chandra, AD Diwan · 2019 · Plants
  89. Rhodamine-Based Metal Chelator: A Potent Inhibitor of Metal-Catalyzed Amyloid Toxicity
    Krishnangsu Pradhan, Gaurav Das, Chirantan Kar, Nabanita Mukherjee, Juhee Khan, Tanushree Mahata, Surajit Barman, Surajit Ghosh · 2020 · ACS Omega
  90. Polysaccharide of Taxus chinensis var. mairei Cheng et L.K.Fu attenuates neurotoxicity and cognitive dysfunction in mice with Alzheimer’s disease
    Senwei Zhang, Lulu Li, Jinting Hu, Ping Ma, Huimin Zhu · 2020 · Pharmaceutical Biology
  91. The Asparaginyl Endopeptidase Legumain: An Emerging Therapeutic Target and Potential Biomarker for Alzheimer’s Disease
    Mingke Song · 2022 · International Journal of Molecular Sciences
  92. Synthesis and evaluation of ethyleneoxylated and allyloxylated chalcone derivatives for imaging of amyloid β plaques by SPECT
    Takeshi Fuchigami, Yūki Yamashita, Mamoru Haratake, Masahiro Ono, Sakura Yoshida, Morio Nakayama · 2014 · Bioorganic & Medicinal Chemistry
  93. Reduced neuronal signaling in the ageing apolipoprotein-E4 targeted replacement female mice
    Shan May Yong, Mei‐Li Lim, Chian‐Ming Low, Boon‐Seng Wong · 2014 · Scientific Reports
  94. Toxic oligomer species of amyloid-β in Alzheimer's disease, a timing issue
    Sylvain Lesné · 2014 · Swiss Medical Weekly
  95. Being human: The role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models
    Andrew A. Sproul · 2015 · Molecular Aspects of Medicine
  96. Thinking outside the brain for cognitive improvement: Is peripheral immunomodulation on the way?
    Xiao Zheng, Xueli Zhang, Kang An, Chongzhao Ran, Guangji Wang, Haiping Hao · 2014 · Neuropharmacology
  97. Altered neurotransmission in the lateral amygdala in aged human apoE4 targeted replacement mice
    Rebecca C. Klein, Shawn K. Acheson, Brian E. Mace, Patrick M. Sullivan, Scott D. Moore · 2014 · Neurobiology of Aging
  98. Highly efficient production of the Alzheimer's γ‐Secretase integral membrane protease complex by a multi‐gene stable integration approach
    Jean‐René Alattia, Mattia Matasci, Mitko I. Dimitrov, Lorène Aeschbach, Sowmya Balasubramanian, David L. Hacker, Florian Maria Wurm, Patrick C. Fraering · 2013 · Biotechnology and Bioengineering
  99. Ginsenoside Rg1 exerts a protective effect against Aβ25–35-induced toxicity in primary cultured rat cortical neurons through the NF-κB/NO pathway
    Jiaying Wu, Hongyu Yang, Qingwei David Zhao, Xingguo Zhang, Yijia Lou · 2016 · International Journal of Molecular Medicine
  100. From Molecular Circuit Dysfunction to Disease
    Chris G. Dulla, Douglas A. Coulter, Jokūbas Žiburkus · 2015 · The Neuroscientist